Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,730.80
(
-1.66%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,028.34
(
-3.94%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 90636

Tuesday, 02/16/2010 5:30:28 AM

Tuesday, February 16, 2010 5:30:28 AM

Post# of 257257
Has Copaxone topped out in the US market?

4Q09 US Copaxone sales of $509M were +33% year-over-year, but they were down 6% vs the $540M booked in 3Q09. Unless the quarter-over-quarter drop was the result of inventory destocking, it could signify that Copaxone demand in the US market has topped out.

Comments?


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now